Fluid and Electrolyte Abnormalities in Patients with Cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-415948-8.00011-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated uric acid increases the risk for acute kidney injury.

  2012cited by this paper
• Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes.

  2012cited by this paper
• The clinical management of tumour lysis syndrome in haematological malignancies

  2011cited by this paper
• Use of Uric Acid-Lowering Agents Limits Experimental Cyclosporine Nephropathy

  2011cited by this paper
• The tumor lysis syndrome.

  2011cited by this paper
• Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma

  2010cited by this paper
• Hyponatremia

  2010cited by this paper
• Mortality after hospitalization with mild, moderate, and severe hyponatremia.

  2009cited by this paper
• Epidemiology of hyponatremia.

  2009cited by this paper
• Nonpeptide vasopressin antagonists: a new group of hormone blockers entering the scene.

  2009cited by this paper
• Inhibiting Dickkopf‐1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma

  2009cited by this paper
• Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients*

  2008cited by this paper
• Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemia.

  2008cited by this paper
• Endocrine functions of bone in mineral metabolism regulation.

  2008cited by this paper
• Combined renal tubular acidosis and diabetes insipidus in hematological disease

  2007cited by this paper
• The syndrome of inappropriate antidiuresis.

  2007cited by this paper
• Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.

  2006cited by this paper
• A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy

  2006cited by this paper
• Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.

  2006cited by this paper
• Incidence and prevalence of hyponatremia.

  2006cited by this paper
• Regulation of cation transport in the distal nephron by mechanical forces.

  2006cited by this paper
• Cetuximab-induced hypomagnesemia in patients with colorectal cancer.

  2006cited by this paper
• Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms

  2006cited by this paper
• Hormonal and cytokine effects of uric acid

  2006cited by this paper
• Role of uric acid in hypertension, renal disease, and metabolic syndrome.

  2005cited by this paper
• Uric Acid – A Uremic Toxin?

  2005cited by this paper
• Hypercalcemia Associated with Cancer

  2005cited by this paper
• Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

  2005cited by this paper
• Cytokines in cancer pathogenesis and cancer therapy

  2004cited by this paper
• Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

  2003cited by this paper
• PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.

  2003cited by this paper
• Hypocalcemia: a pervasive metabolic abnormality in the critically ill.

  2001cited by this paper
• A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis

  2000cited by this paper
• SSRI‐induced hyponatraemia

  1998cited by this paper
• Syndrome of Inappropriate Antidiuretic Hormone Associated with Vinorelbine Therapy

  1998cited by this paper
• Renal magnesium handling: new insights in understanding old problems.

  1997cited by this paper
• A prospective study of patients with lung cancer and hyponatremia of malignancy.

  1997cited by this paper
• Hyponatremia related to medical anticancer treatment

  1996cited by this paper
• Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia.

  1995cited by this paper
• Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.

  1994cited by this paper
• Hyponatremia: epidemiology, pathophysiology, and therapy.

  1993cited by this paper
• Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas.

  1993cited by this paper
• Atrial natriuretic peptides inhibit conductive sodium uptake by rabbit inner medullary collecting duct cells.

  1988cited by this paper
• The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer.

  1986cited by this paper
• Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.

  1986cited by this paper
• Effect of postoperative extradural morphine on ADH secretion.

  1985cited by this paper
• Treatment of hyponatremia.

  1985cited by this paper
• Studies on the antidiuretic effect of cyclophosphamide: vasopressin release and sodium excretion.

  1980cited by this paper
• Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone.

  1979cited by this paper
• Clinical disorders of water metabolism.

  1976cited by this paper
• Effects of flow rate and potassium intake on distal tubular potassium transfer.

  1975cited by this paper
• The syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

  1973cited by this paper
• Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma. Patient with the syndrome of inappropriate secretion of antidiuretic hormone.

  1972cited by this paper
• Mithramycin treatment of hypercalcemia

  1970cited by this paper

• Tracking the Stability of Clinically Relevant Blood Plasma Proteins with Delta-S-Cys-Albumin—A Dilute-and-Shoot LC/MS-Based Marker of Specimen Exposure to Thawed Conditions

  2022cites this paper